Did you mean?

Ind-Swift Laboratories Ltd pe ratio

Vineet Laboratories Ltd pe ratio

Valiant Laboratories Ltd pe ratio

Home

Insights

Ind-Swift Laboratories Ltd P/E Ratio

Ind-Swift Laboratories Ltd P/E Ratio

download
stocks purchased

₹ 0.3 Cr

Volume transacted

stocks purchased

31.5 K

stocks traded

Image

Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB

PE

4.4

Last updated : 21 May 08:14 AM

Key Highlights

    The P/E Ratio of Ind-Swift Laboratories Ltd is 4.4 as of 21 May 08:14 AM .a1#The P/E Ratio of Ind-Swift Laboratories Ltd changed from 6.6 on March 2019 to 6.9 on March 2023 . This represents a CAGR of 0.89% over 5 years. a1#The Latest Trading Price of Ind-Swift Laboratories Ltd is ₹ 108.2 as of 21 May 13:36 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 27.2. The PE Ratio of Finance industry is 13.6. The PE Ratio of IT - Software industry is 27.9. The PE Ratio of Pharmaceuticals industry is 27.7. The PE Ratio of Retail industry is 94.8. The PE Ratio of Textiles industry is 21.1. In 2023a1#The Market Cap of Ind-Swift Laboratories Ltd changed from ₹ 186.71 crore on March 2019 to ₹ 326.4 crore on March 2023 . This represents a CAGR of 11.82% over 5 years. a1#The Revenue of Ind-Swift Laboratories Ltd changed from ₹ 287.56 crore to ₹ 805.18 crore over 8 quarters. This represents a CAGR of 67.33% a1#The EBITDA of Ind-Swift Laboratories Ltd changed from ₹ 60.4 crore to ₹ 374.54 crore over 8 quarters. This represents a CAGR of 149.02% a1#The Net Profit of Ind-Swift Laboratories Ltd changed from ₹ 19.92 crore to ₹ 238.87 crore over 8 quarters. This represents a CAGR of 246.29% a1#The Dividend Payout of Ind-Swift Laboratories Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
Mar '196.6
Mar '200
Mar '210
Mar '220
Mar '236.9

Fundamental Metrics

Market Cap

651 Cr

EPS

25.1

P/E Ratio (TTM) *

4.4

P/B Ratio (TTM) *

0.9

Day’s High

110.55

Day’s Low

107.55

DTE *

0.0

ROE *

15.9

52 Week High

138.25

52 Week Low

65.0

ROCE *

26.0

* All values are consolidated

* All values are consolidated

Image

Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB

PRICE

108.2

-2.00(-1.81%)

stock direction

Last updated : 21 May 13:36

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Ind-Swift Laboratories Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value

Market Value

648

-0.5 X

Value addition

Asset Value

1,194

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

307 Cr

4.4 X

PE Ratio

Market Cap

₹648.18Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

307 Cr

4.4 X

PE Ratio

Market Cap

₹648.18Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Ind-Swift Laboratories Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Ind-Swift Laboratories Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Ind-Swift Laboratories Ltd's Share Price stands at 108.2. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-05-21T13:36:00 is 25.07. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 108.2/ 25.07= 4.38.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Ind-Swift Laboratories Ltd's stock is trading at approximately 4.38 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Ind-Swift Laboratories Ltd’s PE Ratio (BSE: INDSWFTLAB)

    The Price-to-Earnings (PE) ratio, used to assess Ind-Swift Laboratories Ltd's stock (BSE: INDSWFTLAB), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '19187
Mar '20128
Mar '21426
Mar '22392
Mar '23326

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '22288
Sep '22318
Dec '22321
Mar '22314
Jun '23316
Sep '23297
Dec '23295
Mar '23805

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '2260
Sep '2266
Dec '2262
Mar '2247
Jun '2366
Sep '2373
Dec '2359
Mar '23375

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '2220
Sep '2225
Dec '2228
Mar '22-25
Jun '2317
Sep '2332
Dec '2320
Mar '23239

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Ind-Swift Laboratories Ltd

About Ind-Swift Laboratories Ltd

    Ind-Swift Laboratories Ltd was incorporated on January 4, 1995 as a joint venture between Ind-Swift Ltd and Punjab State Industrial Development Corporation. Later, Ind-Swift purchased Punjab State Industrial Development Corporation equity to emerge as a single largest shareholder in the company. They launched four new products namely, Acamprosate (alcohol abstinence), Ezetimibe (anti-hyperlipidemic), Anastrazole (oncology) and Nitazoxanide (anti-diarroheal). During the year 2004-05, the company expanded the production capacity of bulk drugs/ intermediates from 120 TPA to 150 TPA. During the year 2005-06, the company completed and commissioned their new plant at Samba in Jammu & Kashmir to manufacture products for the domestic markets.

Ind-Swift Laboratories Ltd News Hub

News

Ind-Swift Laboratories to discuss results

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 13 ...

Read more

03 May 2024 17:08

News

Ind-Swift Laboratories to table results

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

30 Jan 2024 17:23

News

Ind-Swift Laboratories announces board meeting date

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 7 N...

Read more

01 Nov 2023 12:53

News

Ind-Swift Laboratories to hold EGM

Ind-Swift Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Compa...

Read more

13 Sep 2023 12:13

News

Ind-Swift Laboratories Ltd leads losers in 'B' group

Indian Card Clothing Company Ltd, AAA Technologies Ltd, Peninsula Land Ltd and Fertilizers...

Read more

07 Sep 2023 14:45

News

Ind-Swift Labs hits 52-week high after board approves slump sale of API biz for Rs 1,650 cr

The equity value of the transaction is worth Rs 850 crore, considering an approximate debt...

Read more

06 Sep 2023 15:22

Product Composition by Percentage (Revenue)

FAQs for PE of Ind-Swift Laboratories Ltd

What is Ind-Swift Laboratories Ltd current share price?

The current market price of Ind-Swift Laboratories Ltd as of May 21, 2024 is ₹108.20.

What is Ind-Swift Laboratories Ltd's market cap?

Ind-Swift Laboratories Ltd's market capitalisation stood at ₹648 Cr as of May 21, 2024

What are Ind-Swift Laboratories Ltd's total net assets?

According to Ind-Swift Laboratories Ltd's most recent financial filings, the company's net assets total ₹1194.4 Cr.

Is Ind-Swift Laboratories Ltd making a profit or loss?

Ind-Swift Laboratories Ltd's net Profit as of May 21, 2024 is close to ₹307 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199